1. The GBS hub in Dublin combines the best of
an established global corporation with the
excitement of a technology start-up.
Commitment to work/life
balance and career mobility
Being built from the ground up with
unique growth and leadership
opportunities to help shape our
vision, culture, and operations
Voted one of the Top 20
Irish Workplaces
Global capabilities, people, and
systems to drive continuous
improvement and scalability
Fast pace, leading
technologies and a newly
renovated facility based in
City Centre
A new organization set to
double in size over the
next year
Our Values Drive Our Success
Our strong patient-focused, performance-based culture is guided
by our values:
We have the courage to lead the way.
We are agile and adaptable to meet the changing
needs of our stakeholders.
We deliver on our promises to all of our stakeholders.
We fearlessly innovate to address unmet patient need.
We do the right thing, in the right way.
•
•
•
•
•
Our Strategic Drivers
To expand and sustain our position as a leading biotech, we
concentrate our efforts on four strategic drivers:
Optimize in-line assets via commercial excellence
Advance late-stage pipeline and launch new products
Accelerate top- and bottom-line growth through the
acquisition of core/adjacent assets
•
•
•
Operate a lean and agile organization
Concentrate operations in US and Switzerland
Execute to a high standard by meeting milestones and
delivering on our commitments
•
•
•
Foster and reward a high-performance culture
Attract, develop and retain the best talent
Live our values
•
•
•
Expand our rare diseases expertise and offerings
Reinvest in R&D
Extend our portfolio to new indications and
therapeutic areas
Collaborate globally to advance our scientific and
commercial priorities
•
•
•
•
Growth
Innovation
Efficiency
People
Leadership In Responsibility
Global 100 Most
Sustainable
Corporations in
the World, 2016
Constituent of
the FTSE4Good
Index Series
#1 “Greenest”
Company in the
World, 2016
Global
We market our
products in
100+
countries
68 countries
Offices in
employees worldwide
22,000+ 1
2
3
4
5
6
Total (US$ million)
12,330
2015 Product Sales**
**Includes Baxalta pro
forma 2015 sales
Shire founded its Global Business Services (GBS) on an enthusiasm to
achieve and exceed and a passion for helping others. Our people and
systems drive strong collaboration with partners and deliver world-class
services. A successful GBS enables Shire to strengthen our focus on the
patients we serve.
Shire is the leading global biotechnology company focused on serving
people with rare diseases and other highly specialized conditions. We
strive to develop best-in-class products across our core therapeutic
areas, including Hematology, Immunology, Neuroscience, Ophthalmics,
Lysosomal Storage Disorders, Gastrointestinal/Internal
Medicine/Endocrine, Hereditary Angioedema, and Oncology.
The patient is the focus of everything we do.